TRT denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for trt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Step Therapy for Testosterone Replacement Therapy — and How to Appeal

UnitedHealthcare's step-therapy ("fail-first") policy for testosterone replacement therapy (TRT) typically requires documentation that certain prior clinical steps have been completed before the plan will authorize a specific formulation or product. This may include requiring trial of a lower-tier formulary TRT product, documentation of a specific diagnostic workup, or evaluation by an appropriate specialist. When the claim lacks evidence of these steps, UHC denies coverage pending documentation of step compliance.

### Why This Denial Is Appealable

Step-therapy denials can be overturned when: (a) you have already completed the required steps and the documentation was not included in the original submission; (b) a required step medication or workup is medically inappropriate for you and your prescriber can document why; or (c) your clinical circumstances meet an exception recognized in UHC's own policy. Many states have step-therapy protection laws requiring insurers to honor established treatment histories and provide exceptions when the step agent would be clinically harmful or ineffective. Even without a state law, a well-documented clinical exception letter frequently succeeds at the internal appeal or external review stage.

### Federal Appeal Framework

• Internal appeal: File a formal written internal appeal with UHC. Standard appeals require a decision within 30 days; urgent/expedited appeals within 72 hours.
• External review (ACA §2719): After exhausting internal appeals, an independent IRO applies evidence-based clinical standards — not UHC's internal formulary preferences — to evaluate whether step therapy is clinically appropriate in your case.
• ERISA §503: Employer-plan members are entitled to full-and-fair review, including written disclosure of all criteria, clinical references, and reviewer credentials used in the decision.
• Timeline: File external review within approximately four months of the final internal denial. Expedited review is available when delay poses a risk to your health.

### Concrete Appeal Steps

1. Obtain UHC's full step-therapy policy for TRT — the specific prior steps required, acceptable evidence, and exception criteria. 2. Audit your chart and pharmacy history against every required step. 3. If steps were completed: gather documentation (prescriber notes, pharmacy fill records, lab results) and submit with the internal appeal. 4. If a required step is not appropriate for you: ask your prescriber to document the specific clinical reason with chart support. 5. File the internal appeal; escalate to external review if denied. 6. In states with step-therapy exception laws, cite the applicable state statute in the appeal letter.

### Documentation to Gather

• Diagnosis confirmation: Lab work and chart notes establishing the clinical basis for hypogonadism and the need for TRT.
• Step compliance documentation: For each required prior step — the date it was completed, the clinical outcome, and the prescriber's assessment.
• Pharmacy fill history: Records from your pharmacy confirming fills and dates for any required formulary-tier products.
• Exception rationale (if applicable): A prescriber letter explaining why a required step was not clinically appropriate, citing the specific clinical reason.
• Prescriber medical-necessity letter: A structured letter mapping each step-therapy criterion to chart evidence, and articulating why the prescribed TRT product is the appropriate next step.

### Criteria-Mapping Structure

Obtain UHC's step-therapy policy for TRT and complete the table:

| Step Requirement from UHC Policy | Evidence of Completion or Exception Basis | |---|---| | [Copy each required step verbatim] | [Date, pharmacy record, chart note, or exception rationale] |

Review the FDA-approved prescribing labels at DailyMed for both the required step product and the prescribed product — label language on approved indications and dosing may support your prescriber's clinical rationale.